Literature DB >> 10406819

Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

X P Yang1, Y H Liu, E G Shesely, M Bulagannawar, F Liu, O A Carretero.   

Abstract

We tested the hypothesis that nitric oxide (NO) released by endothelial NO synthase (eNOS) is not only important in blood pressure regulation but also involved in cardiac function and remodeling and in the cardioprotective effect of angiotensin-converting enzyme inhibitors (ACEi). With the use of a 2D Doppler echocardiography system equipped with a 15-MHz linear transducer, we evaluated left ventricular (LV) morphology and function in conscious eNOS knockout mice (eNOS(-/-); n=15) and their wild-type littermates (eNOS(+/+); n=16). We also studied whether in eNOS(-/-) mice (1) myocardial ischemia/reperfusion injury is more severe and (2) the cardioprotective effect of ACEi is diminished or absent. In comparison with the wild type, eNOS(-/-) mice had significantly increased systolic blood pressure (128+/-3 versus 108+/-5 mm Hg; P<0.001) and decreased heart rate (531+/-22 versus 629+/-18 bpm; P<0.001) associated with increased LV posterior wall thickness (0.80+/-0.04 versus 0.64+/-0.02 mm; P<0.001) and LV mass (18.3+/-0.9 versus 13.1+/-0.5 mg/10 g body weight; P<0.01). Despite hypertension and LV hypertrophy, LV chamber dimension, shortening fraction and ejection fraction (indicators of LV contractility), and cardiac output did not differ between the 2 strains, which indicates that LV function in eNOS(-/-) mice is well compensated. We also found that in eNOS(+/+) mice, ACEi decreased the ratio of myocardial infarct size to area at risk from 62.7+/-3.9% to 36.3+/-1.6% (P<0. 001), whereas in eNOS(-/-) mice this effect of ACEi was almost abolished: the ratio of myocardial infarct size to area at risk was 67.2+/-2.9% in the vehicle-treated group and 62.7+/-3.9% in mice treated with ACEi. Moreover, infarct size in vehicle-treated eNOS(-/-) mice was not significantly different from eNOS(+/+) mice given the same treatment. We concluded that (1) endothelium-derived NO plays an important role in the regulation of blood pressure homeostasis; (2) NO released under basal conditions has no significant impact on cardiac function; and (3) ACEi protect the heart against ischemia/reperfusion injury in mice and that this effect is mediated in part by endothelium-derived NO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406819     DOI: 10.1161/01.hyp.34.1.24

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  41 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Muscarinic regulation of cardiac ion channels.

Authors:  Robert D Harvey; Andriy E Belevych
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

3.  Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Zhi-Dong Ge; Danijel Pravdic; Martin Bienengraeber; Phillip F Pratt; John A Auchampach; Garrett J Gross; Judy R Kersten; David C Warltier
Journal:  Anesthesiology       Date:  2010-01       Impact factor: 7.892

4.  Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.

Authors:  Olena Andrukhova; Svetlana Slavic; Ute Zeitz; Sabine C Riesen; Monika S Heppelmann; Tamas D Ambrisko; Mato Markovic; Wolfgang M Kuebler; Reinhold G Erben
Journal:  Mol Endocrinol       Date:  2013-01-01

5.  Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle.

Authors:  Iman Momken; Dominique Fortin; Bernard Serrurier; Xavier Bigard; Renée Ventura-Clapier; Vladimir Veksler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  The effect of salt on renal damage in eNOS-deficient mice.

Authors:  Geraldine Daumerie; Lakeesha Bridges; Sadiqa Yancey; Wendell Davis; Paul Huang; Joseph Loscalzo; Mildred A Pointer
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

7.  Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current.

Authors:  Honglan Wang; Mark J Kohr; Debra G Wheeler; Mark T Ziolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-18       Impact factor: 4.733

8.  Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse.

Authors:  Yiru Guo; Qianhong Li; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Jingyao Mu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2008-01-17       Impact factor: 5.000

Review 9.  Genomic variation and neurohormonal intervention in heart failure.

Authors:  Dennis M McNamara
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

10.  Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.

Authors:  Jorge L Durand; Shankar Mukherjee; Fernando Commodari; Andrea P De Souza; Dazhi Zhao; Fabiana S Machado; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.